Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02100007
Title ME-344 Given in Combination With Hycamtin in Patients With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

ovarian cancer

cervical cancer

lung small cell carcinoma

Therapies

ME-344 + Topotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.